Celldex Therapeutics Inc. (CLDX) Dropped -6.27% or -0.21 To Price $3.14 On Monday


Celldex Therapeutics Inc. (CLDX) dropped -6.27% or -0.21 to $3.14. It is close to 227273 shares traded, which is 39.19% compare to the average total volume 579962. The market cap of CLDX is $43.23 million. The year to date change is -17.15%. The 52 week price range is from $2.75 to $11.62. Price of CLDX have changed -15.40% during last week. It have changed -22.99% over last month, -32.87% over last 3 months, -33.53% over last 6 months and -68.98% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 4.43. It is 41.08% above current price. The 200-day Moving Averages for CLDX is 5.37. It is 71.02% above current price. The 52-week High is 11.62. It is 270.06% from the current price. The 52-week Low is 2.75. It is -12.42% from current price.

There are some statistics of CLDX. It is has market cap $43.23 million. The share outstanding is 13.77 million. The average volume is 579962. The percent of top 15 Institution holding is 12.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -42.83%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -31.25%.


Tags:

Share this post